DelNS1-2019-nCoV-RBD-OPT1

BIOLOGICAL2 trials

Sponsors

The University of Hong Kong, Jiangsu Province Centers for Disease Control and Prevention

Conditions

COVID-19Covid19

Phase 2

To Evaluate Safety & Immunogenicity of DelNS1-2019-nCoV-RBD-OPT1 for COVID-19 in Healthy Adults Received 2 Doses of BNT162b2

The University of Hong KongCovid19

Start: 2022-02-08End: 2024-02-29Target: 150Updated: 2022-10-28

Phase 4

Effectiveness of a Second COVID-19 Vaccine Booster in Chinese Adults

Jiangsu Province Centers for Disease Control and PreventionCOVID-19

Start: 2023-05-18End: 2024-12-31Target: 10000Updated: 2023-05-22

Related Papers

Effectiveness of a booster dose of aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine in adults: a multicenter, partially randomized, platform trial in China.

2025-03-263 citations